COI Pharmaceuticals
Overview
COI Pharmaceuticals is a biotechnology venture entity that offers operational support and infrastructure to biotech companies. Established in 2013, it operates as a Community of Innovation, providing a fully-equipped R&D facility and industry mentors to help entrepreneurial scientists succeed. By eliminating operational distractions, COI Pharmaceuticals enables scientists to focus on advancing their ideas in drug discovery. The company collaborates with various partners to launch and support early-stage life science companies. Notably, in 2015, COI Pharmaceuticals expanded its collaboration with GlaxoSmithKline (GSK) to fund and launch additional companies through the development of clinical candidates. This collaboration has led to the formation of multiple companies, including Sitari Pharmaceuticals and Silarus Therapeutics, which focus on novel treatments for celiac disease and iron overload disorders, respectively. In 2019, COI Pharmaceuticals acquired Calporta Therapeutics, a company developing selective small molecule agonists to TRPML1, with potential applications in treating lysosomal storage and neurodegenerative disorders. This acquisition highlights COI Pharmaceuticals' commitment to advancing innovative therapies in the biotechnology sector.
Investment Focus
- Innovative biotech companies seeking operational support and infrastructure
Portfolio Companies
Reach COI Pharmaceuticals directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about COI Pharmaceuticals
What sectors does COI Pharmaceuticals invest in?
COI Pharmaceuticals invests in Healthcare, Pharmaceuticals and Biotechnology, and is based in San Diego, California, United States. COI Pharmaceuticals is listed as a corporate vc in the ConnectSafely investor database.
What stage does COI Pharmaceuticals invest at?
COI Pharmaceuticals backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage.
Which regions does COI Pharmaceuticals invest in?
COI Pharmaceuticals invests across United States.
Who are the partners at COI Pharmaceuticals?
Team members listed for COI Pharmaceuticals include Victor Knopov (Chief Technology Officer) and Curtis Robak (Director, Information Technology).
What companies has COI Pharmaceuticals invested in?
COI Pharmaceuticals's portfolio includes Sitari Pharmaceuticals, Silarus Therapeutics and Calporta Therapeutics.
How do I contact COI Pharmaceuticals?
COI Pharmaceuticals's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
